GL
JAZZ icon

GLG LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

GLG LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$422K Hold
3,133
– – 0.03% 369
2017
Q3 		$458K Sell
3,133
-127
-4% -$19.2K 0.03% 398
2017
Q2 		$507K Sell
3,260
-379
-10% -$58K 0.03% 410
2017
Q1 		$528K Sell
3,639
-8
-0.2% -$1.04K 0.03% 442
2016
Q4 		$398K Buy
3,647
+232
+7% +$25.8K 0.03% 447
2016
Q3 		$415K Sell
3,415
-302
-8% -$40.7K 0.03% 429
2016
Q2 		$525K Sell
3,717
-631
-15% -$93K 0.04% 365
2016
Q1 		$568K Sell
4,348
-683
-14% -$85K 0.04% 406
2015
Q4 		$707K Sell
5,031
-1,815
-27% -$252K 0.04% 375
2015
Q3 		$909K Sell
6,846
-12
-0.2% -$2.07K 0.02% 425
2015
Q2 		$1.21M Sell
6,858
-30
-0.4% -$5.39K 0.03% 442
2015
Q1 		$1.19M Sell
6,888
-130
-2% -$22.3K 0.03% 408
2014
Q4 		$1.15M Sell
7,018
-8,200
-54% -$1.36M 0.03% 427
2014
Q3 		$2.44M Hold
15,218
– – 0.07% 324
2014
Q2 		$2.24M Hold
15,218
– – 0.07% 348
2014
Q1 		$2.11M Buy
+15,218
New +$2.29M 0.07% 313

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

GLG LLC's JAZZ Position: Q4 2017 in Review

GLG LLC held its Jazz Pharmaceuticals (JAZZ) position steady in Q4 2017 at 3,133 shares worth $422K. The position accounts for 0.03% of the portfolio, ranked #369.

GLG LLC first reported a position in JAZZ in Q1 2014 and has held it in 16 quarters since. The position peaked at $2.44M in Q3 2014. 323 funds tracked by Wall St. Rank hold JAZZ as of Q4 2017.

  • GLG LLC held 3,133 shares of Jazz Pharmaceuticals worth $422K as of Q4 2017.
  • GLG LLC left its Jazz Pharmaceuticals share count unchanged in Q4 2017.
  • Jazz Pharmaceuticals made up 0.03% of GLG LLC's portfolio in Q4 2017, its #369 holding.
  • GLG LLC first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Jazz Pharmaceuticals position peaked at $2.44M in Q3 2014.
  • 323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.